Routt E. Long Term Outcomes for Basal Cell Carcinoma Treated with Vismodegib Extended Alternate Day Dosing. J of Skin [Internet]. 2019Mar.11 [cited 2024Jul.22];3(2):150-1. Available from: https://jofskin.org/index.php/skin/article/view/587